The China Fund, Inc. Announces Date of Annual Meeting of Stockholders
- 20
PR Newswire
BOSTON, Jan. 27, 2022
BOSTON, Jan. 27, 2022 /PRNewswire/ -- The China Fund, Inc. (NYSE: CHN) (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be rescheduled for Wednesday, March 23, 2022 via a virtual forum at 11:00 a.m. Stockholders of record as of January 21, 2022 will be entitled to notice of, and to attend and vote at, the Meeting. The notice for the Meeting will be mailed to shareholders on or about February 16, 2022.
The Fund is a closed-end management investment company with the objective of seeking long-term capital appreciation by investing primarily in equity securities (i) of companies for which the principal securities trading market is the People's Republic of China ("China"), or (ii) of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods and services sold or produced, or have at least 50% of their assets, in China. Shares of the Fund are listed on the New York Stock Exchange under the ticker symbol "CHN."
For further information regarding the Fund and the Fund's holdings, please call (888)-CHN-CALL or visit the Fund's website at www.chinafundinc.com.
View original content:https://www.prnewswire.com/news-releases/the-china-fund-inc-announces-date-of-annual-meeting-of-stockholders-301469796.html
SOURCE The China Fund, Inc.
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- Nordic Fibreboard AS notification of voluntary takeover offer
- Prudential Financial empowers young changemakers with $15,000 each at Emerging Visionaries Summit
- Hyundai 2024 Santa Fe and Kona Named a Wards Best Interiors & UX by WardsAuto
- T-Mobile and EQT Announce Joint Venture to Acquire Lumos and Build Out the Un-carrier's First Fiber Footprint
- EQS-News: NFON AG: Forthcoming merger of Deutsche Telefon Standard GmbH with NFON AG in accordance with section 62(4) sentence 4, (3) sentence 2 of the Umwandlungsgesetz
- Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference